Financial Relationships Between Pharmaceutical Companies and Internal Medicine Societies-Reference-Cited by-同舟云学术

Financial Relationships Between Pharmaceutical Companies and Internal Medicine Societies

Published:2024-04-03 Issue:4 Volume:7 Page:e244777
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Murayama Anju¹²,Higuchi Kenichi¹,Senoo Yuki³

Affiliation:

1. Tohoku University School of Medicine, Sendai, Miyagi, Japan

2. Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York

3. Higashi Totsuka Memorial Hospital, Yokohama, Kanagawa, Japan

Abstract

This cross-sectional study uses payment data publicly disclosed by pharmaceutical companies affiliated with the Japan Pharmaceutical Manufacturers Association to describe their financial relationships with the subspecialty societies of the Japanese Society of Internal Medicine.

Publisher

American Medical Association (AMA)

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2817005/murayama_2024_ld_240027_1711131172.28277.pdf

Reference6 articles.

1. Medical royal colleges receive millions from drug and medical devices companies.;Boytchev;BMJ,2023

2. Association between conflicts of interest and favourable recommendations in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: systematic review.;Nejstgaard;BMJ,2020

3. Pathways to independence: towards producing and using trustworthy evidence.;Moynihan;BMJ,2019

4. Financial conflicts of interest between pharmaceutical companies and executive board members of internal medicine subspecialty societies in Japan between 2016 and 2020.;Murayama;J Eval Clin Pract,2023

5. Pharmaceutical money database: yen for docs. Online database. Medical Governance Research Institute. Medical Governance Research Institute. September 7, 2023. Accessed December 29, 2023. https://yenfordocs.jp/

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-research payments to board-certified cardiologists from pharmaceutical industry in Japan from 2016 to 2019: a retrospective analysis;BMJ Open;2024-07

2. Pharmaceutical company payments to Japanese breast cancer practice guideline authors;Clinical and Translational Discovery;2024-06

3. Conflicts of Interest Among Cardiology Clinical Practice Guideline Authors in Japan;Journal of the American Heart Association;2024-04-16